Friday, July 31, 2015 12:16:46 PM
A couple of items:
1) Despite lackluster sales, MannKind announces it will triple production capacity to support the Afrezza launch. With the added capacity, the company expects to support a demand of more than 300 million cartridges per year.
http://seekingalpha.com/news/2681335-mannkind-triples-afrezza-production-capacity-despite-slow-ramp-up-shares-off-3-percent-premarket
2) One of the largest global ad companies in the world, Havas, is (slowly) starting the DTC campaign in the US
http://www.mmm-online.com/pharmaceutical/sanofi-launches-dtc-campaign-for-afrezza/article/429565/
Havas: Havas is a French multinational advertising and public relations company, headquartered in Paris, France. It operates in more than 100 countries and is one of the largest global advertising and communications groups in the world. Havas consists of two main operational divisions
They did not go for a U.S. based company. They went for a French based company with global reach. You can read it whichever way you decide. My take is Sanofi (a global pharma) is preparing for launches world wide campaign and is just starting to test messages with an initial U.S. campaign, get the market reaction, hone the message, get the approval in the E.U. +, and market with a global reach.
To each their read of the news and their way to connect the dots :)
1) Despite lackluster sales, MannKind announces it will triple production capacity to support the Afrezza launch. With the added capacity, the company expects to support a demand of more than 300 million cartridges per year.
http://seekingalpha.com/news/2681335-mannkind-triples-afrezza-production-capacity-despite-slow-ramp-up-shares-off-3-percent-premarket
2) One of the largest global ad companies in the world, Havas, is (slowly) starting the DTC campaign in the US
http://www.mmm-online.com/pharmaceutical/sanofi-launches-dtc-campaign-for-afrezza/article/429565/
Havas: Havas is a French multinational advertising and public relations company, headquartered in Paris, France. It operates in more than 100 countries and is one of the largest global advertising and communications groups in the world. Havas consists of two main operational divisions
They did not go for a U.S. based company. They went for a French based company with global reach. You can read it whichever way you decide. My take is Sanofi (a global pharma) is preparing for launches world wide campaign and is just starting to test messages with an initial U.S. campaign, get the market reaction, hone the message, get the approval in the E.U. +, and market with a global reach.
To each their read of the news and their way to connect the dots :)
Recent MNKD News
- MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval • GlobeNewswire Inc. • 05/29/2026 06:00:00 PM
- MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes • GlobeNewswire Inc. • 05/29/2026 04:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2026 12:37:11 PM
- MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems • GlobeNewswire Inc. • 05/27/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 01:10:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 01:00:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:56:12 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:52:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:51:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:50:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:49:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:48:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:48:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2026 12:47:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:17:49 PM
- Form 144/A - Report of proposed sale of securities: [Amend] • Edgar (US Regulatory) • 05/14/2026 08:51:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 12:30:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/14/2026 12:30:03 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:34:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 08:34:39 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (Canada) • 05/12/2026 02:30:00 PM
- The $59B Quiet Shift Reshaping How Patients Access Care • PR Newswire (US) • 05/12/2026 02:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 08:05:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 08:03:30 PM
- MannKind Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/06/2026 08:01:00 PM
